Today's Top Health News Story

Does drug touted by Trump work on COVID-19? After data debacle, we still don't know

LONDON (Reuters) - Scientists are resuming COVID-19 trials of the now world-famous drug hydroxychloroquine, as confusion continues to reign about the anti-malarial hailed by U.S. President Donald Trump as a potential "game-changer" in fighting the pandemic. Learn More


More Top Health Stories

Protesters should 'highly consider' getting COVID-19 tests, U.S. official says

NEW YORK (Reuters) - Protesters particularly in cities that have struggled to control the novel coronavirus should "highly consider" getting tested for COVID-19, the illness caused by the virus, a top U.S. health official said on Thursday. More »


U.S. CDC reports 1,842,101 coronavirus cases

(Reuters) - The U.S. Centers for Disease Control and Prevention (CDC) on Thursday reported 1,842,101 cases of the new coronavirus, an increase of 14,676 cases from its previous count, and said that the number of deaths had risen by 827 to 107,029. More »


U.S. doctors group sues FDA for limiting access to drug touted by Trump for COVID-19

(Reuters) - A group of conservative U.S. doctors has sued the Food and Drug Administration for limiting use of the malaria drug hydroxychloroquine for COVID-19, arguing that the therapy should be made widely available to fight the pandemic. More »


Study authors retract influential Lancet hydroxychloroquine article

NEW YORK (Reuters) - Three of the authors of an influential article that found hydroxychloroquine increased the risk of death in COVID-19 patients retracted the study on Thursday, citing concerns about the quality of the data behind it. More »


U.S. health department asks labs to add demographic data to COVID-19 results

(Reuters) - U.S. laboratories testing patients for COVID-19 are required to report data such as a patient's age and ethnicity along with test results, the U.S. Department of Health and Human Services (HHS) said on Thursday. More »


Protesters should 'highly consider' coronavirus tests, U.S. health official says

NEW YORK (Reuters) - A top U.S. health official cautioned on Thursday that protests sweeping across the country could increase the spread of the novel coronavirus, particularly in cities that have struggled to control the outbreak, and that participants should "highly consider" getting tested. More »


AstraZeneca targets two billion doses, poor countries with COVID vaccine deals

(Reuters) - British drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to 2 billion doses in two deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries. More »


French coronavirus death toll up 44 to 29,065

PARIS (Reuters) - Confirmed new coronavirus infections in France rose by 767 to 152,444 on the 25th day since lockdown ended on May 11, the health ministry said in a statement on Thursday. More »


EU to use $2.7 billion fund to buy promising COVID-19 vaccines

BERLIN/BRUSSELS (Reuters) - The European Union is preparing to use an emergency 2.4-billion- euro ($2.7 billion) fund to make advance purchases of promising vaccines against the new coronavirus, EU officials told Reuters. More »


News, Photo and Web Search